Conversely, some researchers argue that the m6A eraser ALKBH5, despite its high expression in HCC patients and association with poor outcomes, upregulates MAP3K8 expression by modulating m6A modification, thereby augmenting hepatoma cell proliferation and metastasis. The gene discussed is MAP3K8; the disease is hepatocellular carcinoma.